CA2222596A1 - Proteine a activite inductrice de la differenciation de lignees de cellules d'erythroleucemie de friend - Google Patents

Proteine a activite inductrice de la differenciation de lignees de cellules d'erythroleucemie de friend Download PDF

Info

Publication number
CA2222596A1
CA2222596A1 CA002222596A CA2222596A CA2222596A1 CA 2222596 A1 CA2222596 A1 CA 2222596A1 CA 002222596 A CA002222596 A CA 002222596A CA 2222596 A CA2222596 A CA 2222596A CA 2222596 A1 CA2222596 A1 CA 2222596A1
Authority
CA
Canada
Prior art keywords
protein
differentiation
cell lines
cells
inducing activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002222596A
Other languages
English (en)
Inventor
Peter Dormer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Publication of CA2222596A1 publication Critical patent/CA2222596A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne une nouvelle protéine ayant au moins une activité inductrice de la différenciation, notamment de lignées de cellules d'érythroleucémie de Friend.
CA002222596A 1996-03-28 1997-03-27 Proteine a activite inductrice de la differenciation de lignees de cellules d'erythroleucemie de friend Abandoned CA2222596A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19612463.8 1996-03-28
DE19612463A DE19612463C2 (de) 1996-03-28 1996-03-28 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen

Publications (1)

Publication Number Publication Date
CA2222596A1 true CA2222596A1 (fr) 1997-10-09

Family

ID=7789798

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002222596A Abandoned CA2222596A1 (fr) 1996-03-28 1997-03-27 Proteine a activite inductrice de la differenciation de lignees de cellules d'erythroleucemie de friend

Country Status (7)

Country Link
EP (1) EP0833909A1 (fr)
JP (1) JPH11507247A (fr)
KR (1) KR19990022011A (fr)
AU (1) AU726786B2 (fr)
CA (1) CA2222596A1 (fr)
DE (1) DE19612463C2 (fr)
WO (1) WO1997037015A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101627020B1 (ko) 2013-12-02 2016-06-02 충북대학교 산학협력단 적 백혈병 세포에서 발현되는 icama4를 인지하는 항체 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032507A (en) * 1987-11-13 1991-07-16 The Salk Institute For Biological Studies Potentiation of erythropoiesis
US5599705A (en) * 1993-11-16 1997-02-04 Cameron; Robert B. In vitro method for producing differentiated universally compatible mature human blood cells

Also Published As

Publication number Publication date
DE19612463C2 (de) 1998-04-30
AU726786B2 (en) 2000-11-23
EP0833909A1 (fr) 1998-04-08
DE19612463A1 (de) 1997-10-02
WO1997037015A1 (fr) 1997-10-09
JPH11507247A (ja) 1999-06-29
AU2874897A (en) 1997-10-22
KR19990022011A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
Introna et al. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene
Baldwin et al. A New Epidermal Growth Factorlike Domain in the Human Core Protein for the Large Cartilage-specific Proteoglycan: Evidence for alternative splicing of the domain
JPWO1998051799A1 (ja) 新規な分化抑制剤
US5972886A (en) Megakaryocyte differentiation factor
EP0815221B1 (fr) Nouveau facteur de croissance et sequence genetique codant ce facteur
DE69736109T2 (de) Differenzierungsinhibitor
US5955594A (en) Nucleic acids encoding proteins for early liver development
CA2130089A1 (fr) Composes proteiques, sequences nucleotidiques codantes, lignee cellulaire productrice et leurs applications
EP0521156A1 (fr) Codage adn pour un recepteur de facteur de stimulation d'une colonie de granulocytes (g-csf)
IE912135A1 (en) Mast cell growth factor
Sato et al. Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell lines
CA2222596A1 (fr) Proteine a activite inductrice de la differenciation de lignees de cellules d'erythroleucemie de friend
Xu et al. Forced expression of Genesis, a winged helix transcriptional repressor isolated from embryonic stem cells, blocks granulocytic differentiation of 32D myeloid cells
IE912281A1 (en) New protein with cell-differentiation or cell-formation¹ability and recombinant process for the production
AU707513B2 (en) A novel growth factor and a genetic sequence encoding same
WO1996040910A1 (fr) Facteurs de croissance humains, sequence de nucleotides codant les facteurs de croissance et leurs procedes d'utilisation
US7160991B1 (en) Vascular endothelial growth factor polypeptides
CN1952129A (zh) Angptl4缺失突变体及其应用
WO1994013800A2 (fr) Preparation a base de proteine mk et son utilisation dans les cultures cellulaires
JP2006212033A (ja) 分化抑制ポリペプチド
WO1998024812A2 (fr) Polypeptides et polynucleotides a6la5a12 et procedes en relation avec leur utilisation
JPH08198899A (ja) 新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物
HK1002963B (en) A novel growth factor and a genetic sequence encoding same
PL185293B1 (pl) Izolowany polipeptyd, izolowana cząsteczka kwasu nukleinowego, sposób otrzymywania polipeptydu, cząsteczka antysensowna, środek farmaceutyczny, komórka gospodarza oraz wektor
JPH05308990A (ja) 新規糖タンパク質、ポリペプチド並びにその製造方法及 び遺伝子

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued